New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 13, 2023 - The FDA announced the approval of Perrigo’s over-the-counter (OTC) Opill (norgestrel), to prevent pregnancy.
Download PDF
Return to publications
